Covered recipient · General Payments record
THOMAS J LISCHWE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2023
$2,093.01
- Reported across 120 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $255.84 | 11 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $125.51 | 4 |
| Exact Sciences Corporation | $40.90 | 2 |
| GlaxoSmithKline, LLC. | $23.10 | 1 |
| Antares Pharma, Inc. | $22.58 | 1 |
| Amgen Inc. | $15.92 | 1 |
| Esperion Therapeutics, Inc. | $14.84 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $12.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.64 | 01/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997777679 | CMS |
| ABBVIE INC. | $33.82 | 01/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997777681 | CMS |
| ABBVIE INC. | $29.13 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997777683 | CMS |
| ABBVIE INC. | $28.92 | 04/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997777685 | CMS |
| Amgen Inc. | $15.92 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020173323 | CMS |
| Antares Pharma, Inc. | $22.58 | 05/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054598617 | CMS |
| Esperion Therapeutics, Inc. | $14.84 | 01/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050741923 | CMS |
| Exact Sciences Corporation | $17.31 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026685539 | CMS |
| Exact Sciences Corporation | $23.59 | 04/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026685551 | CMS |
| GlaxoSmithKline, LLC. | $23.10 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002754141 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $12.99 | 06/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1057399123 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.